{"transactions":[{"id":730981,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T21:20:07.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":19686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":15314,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":19686},"source":{"system":"sec-edgar","filing":"0001707685-26-000010","document":"form4-06222026_050603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000010/form4-06222026_050603.xml","form_type":"4"}},{"id":730980,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:07.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":19686,"price":75.56,"value":1487474.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026."}],"balance_after":70199,"source":{"system":"sec-edgar","filing":"0001707685-26-000010","document":"form4-06222026_050603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000010/form4-06222026_050603.xml","form_type":"4"}},{"id":730979,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:07.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":19686,"price":25.69,"value":505733.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026."}],"balance_after":89885,"source":{"system":"sec-edgar","filing":"0001707685-26-000010","document":"form4-06222026_050603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000010/form4-06222026_050603.xml","form_type":"4"}},{"id":891401,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T22:20:14.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":2494,"price":69.36,"value":172983.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a February 15, 2024 grant of 14,000 RSUs and the vesting of 1,450 RSUs from a February 15, 2024 grant of 2,900 RSUs."}],"balance_after":70199,"source":{"system":"sec-edgar","filing":"0001707685-26-000008","document":"form4-02202026_050211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000008/form4-02202026_050211.xml","form_type":"4"}},{"id":941395,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:15.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":1034,"price":76.45,"value":79049.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs."}],"balance_after":72693,"source":{"system":"sec-edgar","filing":"0001707685-26-000006","document":"form4-01122026_050111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000006/form4-01122026_050111.xml","form_type":"4"}},{"id":943557,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:30.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":1235,"price":77.45,"value":95650.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs."}],"balance_after":73727,"source":{"system":"sec-edgar","filing":"0001707685-26-000004","document":"form4-01082026_050123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000004/form4-01082026_050123.xml","form_type":"4"}},{"id":943556,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:30.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":1381,"price":76.95,"value":106267.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 3, 2025 grant of 14,000 RSUs."}],"balance_after":74962,"source":{"system":"sec-edgar","filing":"0001707685-26-000004","document":"form4-01082026_050123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000004/form4-01082026_050123.xml","form_type":"4"}},{"id":947943,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:32.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":33125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027."}],"balance_after":33125,"derivative":{"exercise_price":76.74,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":33125},"source":{"system":"sec-edgar","filing":"0001707685-26-000002","document":"form4-01062026_050124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000002/form4-01062026_050124.xml","form_type":"4"}},{"id":947942,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:32.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":13250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025."}],"balance_after":76343,"source":{"system":"sec-edgar","filing":"0001707685-26-000002","document":"form4-01062026_050124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000170768526000002/form4-01062026_050124.xml","form_type":"4"}},{"id":1253905,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-21T22:20:20.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":878,"price":50.124,"value":44008.872,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a February 15, 2024 grant of 14,000 RSUs and the vesting of 1,450 RSUs from a February 15, 2024 grant of 2,900 RSUs."}],"balance_after":62564,"source":{"system":"sec-edgar","filing":"0001415889-25-005139","document":"form4-02212025_050215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925005139/form4-02212025_050215.xml","form_type":"4"}},{"id":1253904,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-21T22:20:20.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":879,"price":50.096,"value":44034.384,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a February 15, 2024 grant of 14,000 RSUs and the vesting of 1,450 RSUs from a February 15, 2024 grant of 2,900 RSUs."}],"balance_after":63442,"source":{"system":"sec-edgar","filing":"0001415889-25-005139","document":"form4-02212025_050215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925005139/form4-02212025_050215.xml","form_type":"4"}},{"id":1305753,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-10T22:20:15.000Z","date":"2025-01-08","kind":"sale","planned":true,"acquired":false,"shares":1662,"price":44.5,"value":73959.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from January 6, 2021 grants totaling 8,700 RSUs and the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs."}],"balance_after":64321,"source":{"system":"sec-edgar","filing":"0001415889-25-001295","document":"form4-01102025_050111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001295/form4-01102025_050111.xml","form_type":"4"}},{"id":1305752,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-10T22:20:15.000Z","date":"2025-01-07","kind":"sale","planned":true,"acquired":false,"shares":1291,"price":45.34,"value":58533.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs."}],"balance_after":65983,"source":{"system":"sec-edgar","filing":"0001415889-25-001295","document":"form4-01102025_050111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001295/form4-01102025_050111.xml","form_type":"4"}},{"id":1308703,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T22:20:20.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":35000,"derivative":{"exercise_price":46.54,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-001021","document":"form4-01072025_050113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001021/form4-01072025_050113.xml","form_type":"4"}},{"id":1308702,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:20:20.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024."}],"balance_after":67274,"source":{"system":"sec-edgar","filing":"0001415889-25-001021","document":"form4-01072025_050113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001021/form4-01072025_050113.xml","form_type":"4"}},{"id":1343554,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":14695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":51,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":14695},"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343553,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":3105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable."}],"balance_after":14695,"derivative":{"exercise_price":51,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3105},"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343552,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":4776,"price":52.45,"value":250501.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.15 to $52.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":52428,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343551,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":9919,"price":51.53,"value":511126.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.11 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":57204,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343550,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":14695,"price":51,"value":749445.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."}],"balance_after":67123,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343549,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":608,"price":52.24,"value":31761.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":52428,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343548,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":2497,"price":51.34,"value":128195.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":53036,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1343547,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:07.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":3105,"price":51,"value":158355.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024."}],"balance_after":55533,"source":{"system":"sec-edgar","filing":"0001415889-24-028286","document":"form4-12042024_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924028286/form4-12042024_051203.xml","form_type":"4"}},{"id":1639165,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T22:00:46.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":35000,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-24-004163","document":"form4-02162024_050204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004163/form4-02162024_050204.xml","form_type":"4"}},{"id":1639164,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T22:00:46.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025."}],"balance_after":52428,"source":{"system":"sec-edgar","filing":"0001415889-24-004163","document":"form4-02162024_050204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004163/form4-02162024_050204.xml","form_type":"4"}},{"id":1639163,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T22:00:46.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025."}],"balance_after":49528,"source":{"system":"sec-edgar","filing":"0001415889-24-004163","document":"form4-02162024_050204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004163/form4-02162024_050204.xml","form_type":"4"}},{"id":1664243,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2024-02-01T21:15:26.000Z","date":"2024-01-30","kind":"sale","planned":true,"acquired":false,"shares":318,"price":27.2508,"value":8665.7544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs."}],"balance_after":35528,"source":{"system":"sec-edgar","filing":"0001415889-24-002169","document":"form4-02012024_090204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924002169/form4-02012024_090204.xml","form_type":"4"}},{"id":1681900,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2024-01-10T21:11:22.000Z","date":"2024-01-09","kind":"sale","planned":true,"acquired":false,"shares":1653,"price":29.0148,"value":47961.4644,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs and the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs."}],"balance_after":35846,"source":{"system":"sec-edgar","filing":"0001415889-24-000921","document":"form4-01102024_090117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924000921/form4-01102024_090117.xml","form_type":"4"}},{"id":1681899,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2024-01-10T21:11:22.000Z","date":"2024-01-08","kind":"sale","planned":true,"acquired":false,"shares":1188,"price":28.6403,"value":34024.6764,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023."}],"balance_after":37499,"source":{"system":"sec-edgar","filing":"0001415889-24-000921","document":"form4-01102024_090117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924000921/form4-01102024_090117.xml","form_type":"4"}},{"id":1914375,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":false,"shares":371,"price":33.02,"value":12250.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":371},"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914374,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":false,"shares":4321,"price":33.02,"value":142679.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":4321},"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914373,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":20,"price":55.64,"value":1112.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914372,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":351,"price":55.092,"value":19337.292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.50 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38079,"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914371,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":true,"shares":371,"price":33.02,"value":12250.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":38430,"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914370,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":4321,"price":55.0511,"value":237875.8031,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.50 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1914369,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-04-25T20:09:58.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":true,"shares":4321,"price":33.02,"value":142679.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":42380,"source":{"system":"sec-edgar","filing":"0001415889-23-006833","document":"form4-04252023_080440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006833/form4-04252023_080440.xml","form_type":"4"}},{"id":1934273,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T20:21:47.000Z","date":"2023-03-29","kind":"exercise","planned":true,"acquired":false,"shares":4688,"price":40.45,"value":189629.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":40.45,"expiration_date":"2024-09-23","underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001415889-23-005666","document":"form4-03312023_080336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005666/form4-03312023_080336.xml","form_type":"4"}},{"id":1934272,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-31T20:21:47.000Z","date":"2023-03-29","kind":"sale","planned":true,"acquired":false,"shares":1441,"price":47.7752,"value":68844.0632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-005666","document":"form4-03312023_080336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005666/form4-03312023_080336.xml","form_type":"4"}},{"id":1934271,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-31T20:21:47.000Z","date":"2023-03-29","kind":"sale","planned":true,"acquired":false,"shares":3247,"price":47.798,"value":155200.106,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001415889-23-005666","document":"form4-03312023_080336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005666/form4-03312023_080336.xml","form_type":"4"}},{"id":1934270,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-31T20:21:47.000Z","date":"2023-03-29","kind":"exercise","planned":true,"acquired":true,"shares":4688,"price":40.45,"value":189629.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":42747,"source":{"system":"sec-edgar","filing":"0001415889-23-005666","document":"form4-03312023_080336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005666/form4-03312023_080336.xml","form_type":"4"}},{"id":1936030,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":false,"shares":9729,"price":33.02,"value":321251.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":371,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":9729},"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936029,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":false,"shares":16929,"price":33.02,"value":558995.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":4321,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":16929},"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936028,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":300,"price":46.01,"value":13803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.00 to $46.03 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936027,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":4954,"price":45.3842,"value":224833.3268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38359,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936026,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":4475,"price":44.7058,"value":200058.455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.97 to $44.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":43313,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936025,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":true,"shares":9729,"price":33.02,"value":321251.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":47788,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936024,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":200,"price":46.005,"value":9201.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.00 to $46.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936023,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":8780,"price":45.4156,"value":398748.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":38259,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936022,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":7949,"price":44.7177,"value":355460.9973,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.97 to $44.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":47039,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":1936021,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-03-29T20:22:40.000Z","date":"2023-03-27","kind":"exercise","planned":true,"acquired":true,"shares":16929,"price":33.02,"value":558995.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023."}],"balance_after":54988,"source":{"system":"sec-edgar","filing":"0001415889-23-005566","document":"form4-03292023_080330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923005566/form4-03292023_080330.xml","form_type":"4"}},{"id":2036938,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-02-02T21:23:36.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":325,"price":45.628,"value":14829.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs."}],"balance_after":38059,"source":{"system":"sec-edgar","filing":"0001415889-23-001804","document":"form4-02022023_090225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923001804/form4-02022023_090225.xml","form_type":"4"}},{"id":2055861,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-01-12T21:33:27.000Z","date":"2023-01-11","kind":"sale","acquired":false,"shares":417,"price":44.3596,"value":18497.9532,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs."}],"balance_after":38384,"source":{"system":"sec-edgar","filing":"0001415889-23-000876","document":"form4-01122023_090117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000876/form4-01122023_090117.xml","form_type":"4"}},{"id":2055860,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-01-12T21:33:27.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":489,"price":42.9329,"value":20994.1881,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs."}],"balance_after":38801,"source":{"system":"sec-edgar","filing":"0001415889-23-000876","document":"form4-01122023_090117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000876/form4-01122023_090117.xml","form_type":"4"}},{"id":2056780,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-01-11T23:10:37.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":706,"price":41.6562,"value":29409.2772,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs."}],"balance_after":39290,"source":{"system":"sec-edgar","filing":"0001415889-23-000833","document":"form4-01112023_110128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000833/form4-01112023_110128.xml","form_type":"4"}},{"id":2059245,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:58:57.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":32500,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001415889-23-000694","document":"form4-01092023_090148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000694/form4-01092023_090148.xml","form_type":"4"}},{"id":2059244,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE & CAO"}}],"security":"Common Stock","published_at":"2023-01-09T21:58:57.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 293 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022."}],"balance_after":39996,"source":{"system":"sec-edgar","filing":"0001415889-23-000694","document":"form4-01092023_090148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000694/form4-01092023_090148.xml","form_type":"4"}},{"id":2414769,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-02-03T21:59:11.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":707,"price":40.38,"value":28548.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021."}],"balance_after":25405,"source":{"system":"sec-edgar","filing":"0001179110-22-000841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000841/edgar.xml","form_type":"4"}},{"id":2414768,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-02-03T21:59:11.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":313,"price":40.002,"value":12520.626,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs."}],"balance_after":26112,"source":{"system":"sec-edgar","filing":"0001179110-22-000841","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000841/edgar.xml","form_type":"4"}},{"id":2431202,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:50:35.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":10000,"price":18.01,"value":180100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-22-005976","document":"tm224053-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465922005976/tm224053-1_4seq1.xml","form_type":"4"}},{"id":2431201,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-01-20T21:50:35.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":10000,"price":44,"value":440000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021."}],"balance_after":26425,"source":{"system":"sec-edgar","filing":"0001104659-22-005976","document":"tm224053-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465922005976/tm224053-1_4seq1.xml","form_type":"4"}},{"id":2431200,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-01-20T21:50:35.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":10000,"price":18.01,"value":180100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021."}],"balance_after":36425,"source":{"system":"sec-edgar","filing":"0001104659-22-005976","document":"tm224053-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465922005976/tm224053-1_4seq1.xml","form_type":"4"}},{"id":2431199,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-01-20T21:50:35.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":1428,"price":43.5,"value":62118.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021."}],"balance_after":26425,"source":{"system":"sec-edgar","filing":"0001104659-22-005976","document":"tm224053-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465922005976/tm224053-1_4seq1.xml","form_type":"4"}},{"id":2438185,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:21:35.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023."}],"balance_after":43500,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001179110-22-000401","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000401/edgar.xml","form_type":"4"}},{"id":2438184,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-01-11T21:21:35.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023."}],"balance_after":27853,"source":{"system":"sec-edgar","filing":"0001179110-22-000401","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000401/edgar.xml","form_type":"4"}},{"id":2438183,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-01-11T21:21:35.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":747,"price":38.525,"value":28778.175,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021."}],"balance_after":16253,"source":{"system":"sec-edgar","filing":"0001179110-22-000401","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000401/edgar.xml","form_type":"4"}},{"id":2869875,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-10T21:24:29.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":2657,"price":33.02,"value":87734.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":21250,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2657},"source":{"system":"sec-edgar","filing":"0001179110-21-001510","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021001510/edgar.xml","form_type":"4"}},{"id":2869874,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-02-10T21:24:29.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":2657,"price":66,"value":175362.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":16509,"source":{"system":"sec-edgar","filing":"0001179110-21-001510","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021001510/edgar.xml","form_type":"4"}},{"id":2869873,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-02-10T21:24:29.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":2657,"price":33.02,"value":87734.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":19166,"source":{"system":"sec-edgar","filing":"0001179110-21-001510","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021001510/edgar.xml","form_type":"4"}},{"id":2882806,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-02-03T12:46:36.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":652,"price":57.64,"value":37581.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":16509,"source":{"system":"sec-edgar","filing":"0001179110-21-001131","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021001131/edgar.xml","form_type":"4"}},{"id":2882805,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-02-03T12:46:36.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":368,"price":56.956,"value":20959.808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs."}],"balance_after":17161,"source":{"system":"sec-edgar","filing":"0001179110-21-001131","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021001131/edgar.xml","form_type":"4"}},{"id":2906425,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":2500,"price":18.01,"value":45025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":10000,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906424,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right To Buy)","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":788,"price":11.23,"value":8849.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":788},"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906423,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":2500,"price":66.57,"value":166425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":17529,"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906422,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":2500,"price":18.01,"value":45025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":20029,"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906421,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":788,"price":66.57,"value":52457.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":17529,"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906420,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":788,"price":11.23,"value":8849.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":18317,"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2906419,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-15T21:04:56.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":659,"price":66.57,"value":43869.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020."}],"balance_after":17529,"source":{"system":"sec-edgar","filing":"0001179110-21-000648","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000648/edgar.xml","form_type":"4"}},{"id":2912648,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T22:14:19.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":50750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022."}],"balance_after":50750,"derivative":{"exercise_price":66.49,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":50750},"source":{"system":"sec-edgar","filing":"0001179110-21-000468","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000468/edgar.xml","form_type":"4"}},{"id":2912647,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-08T22:14:19.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022."}],"balance_after":18188,"source":{"system":"sec-edgar","filing":"0001179110-21-000468","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000468/edgar.xml","form_type":"4"}},{"id":2914028,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2021-01-07T21:55:58.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":316,"price":62.37,"value":19708.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 242 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2020."}],"balance_after":9488,"source":{"system":"sec-edgar","filing":"0001179110-21-000412","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000412/edgar.xml","form_type":"4"}},{"id":2990184,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":23907,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2656},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990183,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":10625,"price":33.02,"value":350837.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":26563,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990182,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":37188,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2656},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990181,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020."}],"balance_after":39844,"derivative":{"exercise_price":33.02,"expiration_date":"2029-01-21","underlying":"Common Stock","underlying_shares":2656},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990180,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":8055,"price":30.86,"value":248577.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.86,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":8055},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990179,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":2500,"price":18.01,"value":45025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":12500,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990178,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":355,"price":18.01,"value":6393.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019."}],"balance_after":15000,"derivative":{"exercise_price":18.01,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":355},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990177,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":688,"price":30.86,"value":21231.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":8055,"derivative":{"exercise_price":30.86,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990176,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":1567,"price":30.86,"value":48357.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Currently exercisable."}],"balance_after":8743,"derivative":{"exercise_price":30.86,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990175,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":2656,"price":60,"value":159360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990174,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":12218,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990173,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":10625,"price":60,"value":637500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990172,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":10625,"price":33.02,"value":350837.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":20187,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990171,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":2656,"price":60,"value":159360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990170,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":12218,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990169,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":2656,"price":60,"value":159360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990168,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":2656,"price":33.02,"value":87701.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":12218,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990167,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":8055,"price":60.2,"value":484911.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990166,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":8055,"price":30.86,"value":248577.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":17617,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}},{"id":2990165,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":36498,"kind":"person","name":"Utter Christine Marie","position":1,"cik":"0001707685","reported_name":"Utter Christine Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-11-06T21:35:55.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":2500,"price":60,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001179110-20-010870","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911020010870/edgar.xml","form_type":"4"}}],"next_cursor":"2020-11-06T21:35:55.000000Z,2990165"}